Oxford Nanopore Technologies Stock
Nanopore-based electronic systems
About Oxford Nanopore Technologies Stock
Oxford Nanopore Technologies Ltd. develops technologies for molecular detection and analysis in the United Kingdom. The company offers BASE technology, a system for DNA sequencing that employs nanopores to process, identify, and record DNA bases in sequence. Its technologies are used in DNA sequencing, diagnostics, drug development, biomolecular interaction, ion channel screening, and defense applications. The company was formerly known as Oxford NanoLabs, Ltd. and changed its name to Oxford Nanopore Technologies Ltd. in May 2008. Oxford Nanopore Technologies Ltd. was founded in 2005 and is based in Kidlington, the United Kingdom.
Investors
Amgen Ventures
GT Healthcare Capital Partners
Lansdowne Partners
Woodford Investment Management
Funding History
| May 2005 | $896K |
|---|---|
| May 2006 | $10.3M |
| March 2008 | $10.0M |
| April 2010 | $28.0M |
| April 2011 | $25.0M |
| May 2012 | $31.4M |
| October 2013 | $40.0M |
| August 2014 | $59.0M |
| July 2015 | $70.0M |
Management
CEO
Gordon Sanghera
CSO
John Milton
CTO
Clive Brown
Press
Genome Web - Mar, 25 2019
PR NewsWire - Mar, 12 2019
Bio IT World - Feb, 5 2019
Financial Times - Oct, 18 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Oxford Nanopore Technologies or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
